» Articles » PMID: 32393355

Psychiatric Disorders Risk in Patients with Iron Deficiency Anemia and Association with Iron Supplementation Medications: a Nationwide Database Analysis

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2020 May 13
PMID 32393355
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It has been shown that iron deficiency anemia (IDA) is associated with psychosocial consequences and psychiatric morbidity. However, the association between adults with IDA and psychiatric disorders has not been clarified. The purpose of this study was to investigate the psychiatric disorder morbidity of an IDA group in comparison with a non-IDA group and to examine the risk of psychiatric disorders in IDA patients treated with iron supplementation.

Methods: All study subjects were 20 years of age or over with newly diagnosed IDA enrolled in the Taiwan National Health Insurance Database from 2000 to 2012. We matched IDA and non-IDA subjects according to age and gender in a 1:2 ratio. Our primary outcome was diagnosis of psychiatric disorders and the patients were monitored until the end of 2013. A multivariate Cox proportional hazards regression model was used to explore the risk of psychiatric disorders in patients with IDA after adjustment for confounders, including demographic characteristics and comorbidities.

Results: The adjusted hazard ratios (aHRs) of psychiatric disorders was 1.52 (95% CI = 1.45-1.59) in the IDA group compared with the non-IDA group. Among the different types of psychiatric disorders, the IDA group was associated with significantly higher incidence and risks of anxiety disorders, depression, sleep disorders, and psychotic disorders (p <  0.05). Furthermore, iron supplementation in IDA subjects was associated with a significantly lower risk of psychiatric disorders compared to non-iron supplementation in IDA patients.

Conclusions: Our study indicates that IDA subjects had an increased risk of psychiatric disorders, regardless of other confounders. In IDA patients, iron supplementation was associated with a decreased risk of psychiatric disorders. Moreover, IDA patients receiving iron supplementation also had a lower risk of sleep disorders.

Citing Articles

Prevalence, sub-types, and associated factors of anemia among inpatients at a tertiary psychiatric hospital in Tanzania: a cross-sectional study.

Msigwa V, Morawej Z, Kinyaga A, Matovelo S, Nyundo A BMC Psychiatry. 2025; 25(1):179.

PMID: 40011845 PMC: 11866589. DOI: 10.1186/s12888-025-06491-2.


Depression and Anxiety Among Adolescents in Northern Sudan: A School-Based Cross-Sectional Study.

Hassan A, Idrees M, Al-Nafeesah A, Alharbi H, AlEed A, Adam I Medicina (Kaunas). 2025; 61(2).

PMID: 40005346 PMC: 11857361. DOI: 10.3390/medicina61020228.


Dietary Iron Intake and Mental and Behavioral Disorders Due to Use of Tobacco: A UK Biobank Study.

Qi X, Zhang R, Zhu H, Luo J, Zhang Q, Wang W Nutrients. 2025; 17(1.

PMID: 39796473 PMC: 11722800. DOI: 10.3390/nu17010039.


Micronutrients and Major Depression: A Mendelian Randomisation Study.

Carnegie R, Zheng J, Borges M, Jones H, Wade K, Sallis H Nutrients. 2024; 16(21).

PMID: 39519523 PMC: 11547740. DOI: 10.3390/nu16213690.


Association of Gestational Iron-deficiency Anemia with Antenatal Depression among Pregnant Women: A Case-control Study from Tertiary Care Hospitals, Lahore.

Zia E, Tariq A, Ayub F, Khan T, Bukhsh A, Suleiman A J Res Pharm Pract. 2024; 13(1):7-13.

PMID: 39483995 PMC: 11524573. DOI: 10.4103/jrpp.jrpp_15_24.


References
1.
Atkinson H, Cesari M, Kritchevsky S, Penninx B, Fried L, Guralnik J . Predictors of combined cognitive and physical decline. J Am Geriatr Soc. 2005; 53(7):1197-202. DOI: 10.1111/j.1532-5415.2005.53362.x. View

2.
Hidese S, Saito K, Asano S, Kunugi H . Association between iron-deficiency anemia and depression: A web-based Japanese investigation. Psychiatry Clin Neurosci. 2018; 72(7):513-521. DOI: 10.1111/pcn.12656. View

3.
Dhur A, Galan P, Hercberg S . Iron status, immune capacity and resistance to infections. Comp Biochem Physiol A Comp Physiol. 1989; 94(1):11-9. DOI: 10.1016/0300-9629(89)90776-7. View

4.
Belmaker R, Agam G . Major depressive disorder. N Engl J Med. 2008; 358(1):55-68. DOI: 10.1056/NEJMra073096. View

5.
Hong C, Huang Y, Liu H, Chiou H, Chan L, Chien L . Newly Diagnosed Anemia Increases Risk of Parkinson's disease: A Population-Based Cohort Study. Sci Rep. 2016; 6:29651. PMC: 4944159. DOI: 10.1038/srep29651. View